Search
What are you looking for?
Start main content

Press Releases

Press Releases

https://www.med.cuhk.edu.hk/press-releases/cuhk-opens-sh-ho-urology-centre-to-promote-earlier-diagnosis-and-management-of-prostate-cancer-to-the-territory
https://www.med.cuhk.edu.hk/press-releases/cuhk-opens-sh-ho-urology-centre-to-promote-earlier-diagnosis-and-management-of-prostate-cancer-to-the-territory

CUHK Opens S.H. Ho Urology Centre to Promote Earlier Diagnosis and Management of Prostate Cancer to the Territory

With the generous donation from the S.H. Ho Foundation, the S.H. Ho Urology Centre at the Department of Surgery of The Chinese University of Hong Kong (CUHK) opened today (8 November).  Officiating guests included Prof. Joseph J.Y. Sung, Vice-Chancellor and President, CUHK; Dr. David Tzu-cho Ho, Chairman, The S.H. Ho Foundation Limited; Dr. Tzu-leung Ho, Governor, The S.H. Ho Foundation Limited; Prof. Francis K.L. Chan, Dean, Faculty of Medicine, CUHK; Prof. Paul B.S. Lai, Chairman, Department of Surgery, CUHK; and Prof. Anthony C.F. Ng, Director, The S.H. Ho Urology Centre, Department of Surgery, CUHK.  The key mission of the Centre is for the promotion of urological health in Hong Kong and regional area, through physicians and public education on urological diseases management, as well as basic and clinical research, in particular for the establishment of local Chinese experience and database in prostate cancer. Among all urological diseases, prostate cancer will be one of the main focused research areas of the Centre.

 

(From Left) Prof. Paul B.S. Lai, Chairman, Department of Surgery, CUHK; Prof. Joseph J.Y. Sung, Vice-Chancellor and President, CUHK; Dr. David Tzu-cho Ho, Chairman, The S.H. Ho Foundation Limited; Dr. Tzu-leung Ho, Governor, The S.H. Ho Foundation Limited; Prof. Francis K.L. Chan, Dean, Faculty of Medicine, CUHK and Prof. Anthony C.F. Ng, Director, The S.H. Ho Urology Centre, Department of Surgery, CUHK officiate the Opening Ceremony of The S.H. Ho Urology Centre.

(From Left) Prof. Paul B.S. Lai, Chairman, Department of Surgery, CUHK; Prof. Joseph J.Y. Sung, Vice-Chancellor and President, CUHK; Dr. David Tzu-cho Ho, Chairman, The S.H. Ho Foundation Limited; Dr. Tzu-leung Ho, Governor, The S.H. Ho Foundation Limited; Prof. Francis K.L. Chan, Dean, Faculty of Medicine, CUHK and Prof. Anthony C.F. Ng, Director, The S.H. Ho Urology Centre, Department of Surgery, CUHK officiate the Opening Ceremony of The S.H. Ho Urology Centre.

Prostate cancer is the top leading cancer in Caucasian male and the third common cancer in Hong Kong male. The Urology Division of CUHK has conducted a study on the diagnosis of prostate cancer. The study reveals the Prostate Health Index (phi), a new test approved by the US Food and Drug Administration (FDA), improves diagnostic accuracy and hence avoids unnecessary interventional prostatic biopsy in Hong Kong population.

 

Prostate cancer is well known of its strong genetic predisposition in its development. Studies in Caucasian population had identified some genetic markers in association with the risk of prostate cancer. However, in a recent study involving more than 10,000 prostate cancer patients from the CUHK’s Urology Division and six other international institutes discovered that there are two genetic variants significantly associated with the occurrence of prostate cancer in the European-descent patients, but was not whereas identified in Hong Kong Chinese patients. The result suggested that these genetic variants are probably not related to the development of prostate cancer in Hong Kong population and may not be useful for predicting the individual risk of developing prostate cancer and its aggressiveness in Hong Kong population. Therefore, before further investigation, Hong Kong may still need to rely on current approaches for the diagnosis of prostate cancer. The research was published in the leading international journal Nature Genetics (2012; Issue No 44(12) p1326-9).

 

Prostate specific antigen testing (PSA-testing) is currently the main diagnostic tool for prostate cancer in Hong Kong. However, the use of PSA-testing for early prostate cancer detection is always criticized for its low predictive value which may lead to unnecessary prostatic biopsy. The Urology Division recently conducted a study on the effectiveness of Prostate Health Index (phi) in Hong Kong population. In the study of 230 patients who have slight elevated serum PSA level (4 – 10 ng/ml), the phi test can help to avoid more than 40% prostatic biopsy while maintaining a 90% sensitivity in diagnosing prostate cancer. The research validates the effectiveness of phi test in Hong Kong Chinese population, which can significantly decrease the number of invasive prostatic biopsy. In another CUHK study amongst patients diagnosed to have early prostate cancer in the past two years, the group noticed that only a small proportion of PSA test was initiated by routine body check, while the others were ordered by physicians during various medical consultations. This reflected that regular PSA-testing is not common in Hong Kong and the diagnosis of prostate cancer at early stage relies on physicians’ awareness and initiation.

 

Prof. Anthony C.F. Ng presents his recent study findings on the diagnosis of prostate cancer.

Prof. Anthony C.F. Ng presents his recent study findings on the diagnosis of prostate cancer.

Prof. Anthony Ng, Professor of the Division of Urology, Department of Surgery at CUHK said, ‘With the aging population and westernization lifestyle, the incidence of prostate cancer will increase continuously. Our studies have shown that findings on Western population may not be directly applied to the Chinese or Asian population. Therefore, local investigations and validations have an important role on the development of prostate cancer diagnosis and treatment in Hong Kong. We are indebted to the S.H. Ho Foundation for its benevolence in opening of the S.H. Ho Urology Centre, which will continue our works on establishment of local database in prostate cancer and also education for the public and health care providers about the importance of earlier diagnosis and management of prostate cancer.’

More Press Releases

CU Medicine Studies Highlight Smoking as a Contributing Factor for Bladder Cancer and  Develop an International Collaborative Consensus on En Bloc Resection to Treat the Disease

CU Medicine Studies Highlight Smoking as a Contributing Factor for Bladder Cancer and Develop an International Collaborative Consensus on En Bloc Resection to Treat the Disease

Research
CUHK and HKBU Launch Spermine Risk Score for Prostate Cancer Diagnosis

CUHK and HKBU Launch Spermine Risk Score for Prostate Cancer Diagnosis

Research
CUHK Identifies Outcome Indicators for Benign Prostatic Hyperplasia Patients Receiving Prostatic Artery Embolisation

CUHK Identifies Outcome Indicators for Benign Prostatic Hyperplasia Patients Receiving Prostatic Artery Embolisation

Research
CUHK Successfully Conducted the World’s First Multi-Specialty Clinical Trial Using the Next Generation Single Port Robotic Surgical System

CUHK Successfully Conducted the World’s First Multi-Specialty Clinical Trial Using the Next Generation Single Port Robotic Surgical System

Surgical advancement
CUHK’s New Prostatic Artery Embolization Shows 90% Success Rate in Relieving Symptoms of Benign Prostatic Hyperplasia

CUHK’s New Prostatic Artery Embolization Shows 90% Success Rate in Relieving Symptoms of Benign Prostatic Hyperplasia

Clinical service
CUHK Assessed and Treated Over 300 Young Ketamine Abusers with Urinary Tract Dysfunction Latest Research Reveals Effectiveness of Integrated Anti-inflammatory Therapy

CUHK Assessed and Treated Over 300 Young Ketamine Abusers with Urinary Tract Dysfunction Latest Research Reveals Effectiveness of Integrated Anti-inflammatory Therapy

Research
Results of the First 3,500 Participants of the CUHK Jockey Club Multi-Cancer Prevention Programme Demonstrate that “One-stop Multi-Cancer Screening” is Effective

Results of the First 3,500 Participants of the CUHK Jockey Club Multi-Cancer Prevention Programme Demonstrate that “One-stop Multi-Cancer Screening” is Effective

Health Campaign
CU Medicine Survey Shows Global Urological Services have been Significantly Deferred due to COVID-19 Pandemic

CU Medicine Survey Shows Global Urological Services have been Significantly Deferred due to COVID-19 Pandemic

Research
World’s First Large-scale Epidemiological Survey on Adolescents by CUHK Reveals Abuse of Methamphetamine Associated with Increased Risk of Developing Lower Urinary Tract Symptoms

World’s First Large-scale Epidemiological Survey on Adolescents by CUHK Reveals Abuse of Methamphetamine Associated with Increased Risk of Developing Lower Urinary Tract Symptoms

Clinical service
CUHK Establishes New Hybrid Cardiovascular Operating Theatre and Multidisciplinary Team Significantly Reducing Operation Time and Risk of Thoracic Aortic Surgery

CUHK Establishes New Hybrid Cardiovascular Operating Theatre and Multidisciplinary Team Significantly Reducing Operation Time and Risk of Thoracic Aortic Surgery

Clinical service
CUHK's Youth Urological Treatment Centre Opens Today Territory's First Centre to Provide Urological Assessment and Treatment to Young Drug Abusers

CUHK's Youth Urological Treatment Centre Opens Today Territory's First Centre to Provide Urological Assessment and Treatment to Young Drug Abusers

Donation
CUHK Discovers Drug Dosage Brings Negative Impact on Bladder Function among Young People

CUHK Discovers Drug Dosage Brings Negative Impact on Bladder Function among Young People

Research

Our Expert List

Many experts under the Faculty of Medicine are available for media interview.
Please click here for the expert list or contact us.